Kemwell adds cGMP pilot plant to expand capabilities in India

- Last updated on GMT

Related tags: Managing director

Kemwell Biopharma has added a 7,500 sq ft cGMP pilot plant to complement its commercial-scale production facility in Bangalore, India.

Opening of the development facility, which is located next to commercial-scale manufacturing assets, gives Kemwell capabilities for handling formulation of a range of dosage forms. Kemwell says demand for these services has grown.

We are seeing an increasing demand for contract development services in the global market​”, Anurag Bagaria, managing director at Kemwell, said. Kemwell employs 80 scientists at the lab but can scale-up to a headcount of 150 if demand continues to grow.

Related topics: Contract Manufacturing & Logistics

Related news

Show more

Follow us

Featured Events

View more

Products

View more

Webinars